Skip to main content

Table 4 Prognostic factors associated with treatment failure (multivariate analysis)

From: Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France

 

OR [95% CI]

p

Age

0,94 [0.91–0.97]

0.001

Sex

0.86 [0.30–2.44]

0.773

Rifampicin dosage, mg/kg/day

1,02 [0.9–1.15]

0.753

Treatment duration, days

1,05 [1.03–1.07]

< 0.001

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us